NL186088C - PROCESS FOR PREPARING A MEDICINAL PRODUCT, WITH AN EFFECT ON THE CENTRAL NERVOUS SYSTEM CONTAINING AT LEAST ONE DERIVATIVE OF AN AMINO-THIENOBENZO-N-HETEROSOVEN COMPOUND, AND PROCESS FOR THE PREPARATION OF THIS PRODUCT - Google Patents

PROCESS FOR PREPARING A MEDICINAL PRODUCT, WITH AN EFFECT ON THE CENTRAL NERVOUS SYSTEM CONTAINING AT LEAST ONE DERIVATIVE OF AN AMINO-THIENOBENZO-N-HETEROSOVEN COMPOUND, AND PROCESS FOR THE PREPARATION OF THIS PRODUCT

Info

Publication number
NL186088C
NL186088C NLAANVRAGE7513833,A NL7513833A NL186088C NL 186088 C NL186088 C NL 186088C NL 7513833 A NL7513833 A NL 7513833A NL 186088 C NL186088 C NL 186088C
Authority
NL
Netherlands
Prior art keywords
product
thienobenzo
heterosoven
derivative
amino
Prior art date
Application number
NLAANVRAGE7513833,A
Other languages
Dutch (nl)
Other versions
NL7513833A (en
NL186088B (en
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10459213&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL186088(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of NL7513833A publication Critical patent/NL7513833A/en
Publication of NL186088B publication Critical patent/NL186088B/en
Application granted granted Critical
Publication of NL186088C publication Critical patent/NL186088C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NLAANVRAGE7513833,A 1974-11-26 1975-11-26 PROCESS FOR PREPARING A MEDICINAL PRODUCT, WITH AN EFFECT ON THE CENTRAL NERVOUS SYSTEM CONTAINING AT LEAST ONE DERIVATIVE OF AN AMINO-THIENOBENZO-N-HETEROSOVEN COMPOUND, AND PROCESS FOR THE PREPARATION OF THIS PRODUCT NL186088C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB51240/74A GB1533235A (en) 1974-11-26 1974-11-26 Benzodiazepine derivatives

Publications (3)

Publication Number Publication Date
NL7513833A NL7513833A (en) 1976-05-31
NL186088B NL186088B (en) 1990-04-17
NL186088C true NL186088C (en) 1990-09-17

Family

ID=10459213

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7513833,A NL186088C (en) 1974-11-26 1975-11-26 PROCESS FOR PREPARING A MEDICINAL PRODUCT, WITH AN EFFECT ON THE CENTRAL NERVOUS SYSTEM CONTAINING AT LEAST ONE DERIVATIVE OF AN AMINO-THIENOBENZO-N-HETEROSOVEN COMPOUND, AND PROCESS FOR THE PREPARATION OF THIS PRODUCT

Country Status (30)

Country Link
JP (1) JPS6044314B2 (en)
AR (1) AR221203A1 (en)
AT (1) AT351547B (en)
AU (1) AU506340B2 (en)
BE (1) BE835932A (en)
BG (1) BG29573A3 (en)
CA (1) CA1075687A (en)
CH (2) CH613454A5 (en)
CS (1) CS236753B2 (en)
DD (1) DD123343A5 (en)
DE (1) DE2552403C2 (en)
DK (1) DK146887C (en)
ES (1) ES443011A1 (en)
FR (1) FR2292479A1 (en)
GB (1) GB1533235A (en)
HK (1) HK58681A (en)
HU (1) HU172493B (en)
IE (1) IE42564B1 (en)
IL (1) IL48502A (en)
KE (1) KE3163A (en)
MY (1) MY8200149A (en)
NL (1) NL186088C (en)
NZ (1) NZ179335A (en)
PH (2) PH11669A (en)
PL (1) PL100135B1 (en)
RO (1) RO69912A (en)
SE (2) SE421209B (en)
SU (2) SU629879A3 (en)
YU (1) YU298375A (en)
ZA (1) ZA757344B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL62792A (en) * 1980-05-07 1985-02-28 Byk Gulden Lomberg Chem Fab Acylated dihydrothienodiazepinone compounds,process for their preparation,and medicaments containing them
GB8819059D0 (en) * 1988-08-11 1988-09-14 Lilly Industries Ltd Benzodiazepine compounds & their use as pharmaceuticals
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
DE69329887T2 (en) * 1992-05-29 2001-05-23 Eli Lilly And Co., Ltd. Thienobenzodiazepine derivatives for the treatment of disorders of the central nervous system
US6043358A (en) 1995-11-01 2000-03-28 Merck & Co., Inc. Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases
AU700078B2 (en) * 1995-11-01 1998-12-17 Merck & Co., Inc. Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases
AU739385B2 (en) * 1997-09-02 2001-10-11 Mitsubishi Pharma Corporation Condensed thiophene compounds and pharmaceutical use thereof
PL199016B1 (en) * 2002-06-20 2008-08-29 Adamed Sp Z Oo Method of manufacture of alanzapine, new derivative of n-demethyl olanzapine and method of manufacture of new derivative of n-demethyl olanzapine
SI21270A (en) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Crystal forms of olanzapine and procedures for their preparation
DE10301923B3 (en) 2003-01-17 2004-09-16 Krka Tovarna Zdravil, D.D. Process and intermediates for the production of olanzapine
AR047460A1 (en) * 2004-01-27 2006-01-18 Synthon Bv PROCESS FOR THE MANUFACTURE OF 2-METHYL-4- (4-METHYL-1-PIPERAZINYL) ACETATE -10H-TIENO [2,3-B] [1,5] BENZODIAZEPIN (OLANZAPINE ACETATE)
AR048272A1 (en) 2004-03-18 2006-04-12 Lek Pharmaceuticals SYNTHESIS OF 2 METHYL - 4- (4- METHYL -1- PIPERAZINIL) - 10 H- TIENO (2,3-B) (1,5) BENZODIAZEPIN AND ITS SALTS, METHODS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING IT AND ITS USE IN THE MANUFACTURE OF MEDICINES FOR THE TREATMENT OF MENTAL DISEASES.
RU2485125C2 (en) * 2004-06-30 2013-06-20 Эсерсис, Инк. SUBSTITUTED AZEPINE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING DISEASES, DISORDERS AND/OR PATHOLOGICAL CONDITIONS WHEREIN 5HT2c-RECEPTOR FUNCTION MODULATION IS DESIRABLE
EP2292624A1 (en) 2009-07-20 2011-03-09 LEK Pharmaceuticals d.d. Process for the purification of olanzapine

Also Published As

Publication number Publication date
SU629879A3 (en) 1978-10-25
IE42564L (en) 1976-05-26
SE421209B (en) 1981-12-07
DK524175A (en) 1976-05-27
HU172493B (en) 1978-09-28
JPS5176296A (en) 1976-07-01
BG29573A3 (en) 1980-12-12
DE2552403A1 (en) 1976-08-12
DK146887B (en) 1984-01-30
HK58681A (en) 1981-12-04
RO69912A (en) 1980-08-15
DE2552403C2 (en) 1986-06-19
YU298375A (en) 1982-10-31
DK146887C (en) 1984-07-09
NZ179335A (en) 1978-11-13
KE3163A (en) 1981-10-16
JPS6044314B2 (en) 1985-10-02
GB1533235A (en) 1978-11-22
ES443011A1 (en) 1977-07-01
AU506340B2 (en) 1979-12-20
SE429045B (en) 1983-08-08
CS236753B2 (en) 1985-05-15
CH613455A5 (en) 1979-09-28
DD123343A5 (en) 1976-12-12
SE7513185L (en) 1976-05-27
AU8685875A (en) 1977-05-26
SE7812194L (en) 1978-11-27
AR221203A1 (en) 1981-01-15
PH24534A (en) 1990-08-03
PL100135B1 (en) 1978-09-30
AT351547B (en) 1979-07-25
ZA757344B (en) 1976-11-24
BE835932A (en) 1976-05-25
CA1075687A (en) 1980-04-15
ATA898275A (en) 1979-01-15
FR2292479A1 (en) 1976-06-25
FR2292479B1 (en) 1978-07-28
CH613454A5 (en) 1979-09-28
IL48502A0 (en) 1976-01-30
PH11669A (en) 1978-05-19
IE42564B1 (en) 1980-09-10
MY8200149A (en) 1982-12-31
NL7513833A (en) 1976-05-31
NL186088B (en) 1990-04-17
IL48502A (en) 1980-01-31
SU626702A3 (en) 1978-09-30

Similar Documents

Publication Publication Date Title
NL7408985A (en) METHOD FOR PREPARING A MEDICINAL PRODUCT WITH FIBRINOLYTIC ACTION.
NL162904B (en) PROCESS FOR PREPARING AN N-CARBAMOYL-10,11-DIHYDRO-5H-DIBENZOB,F AZEPINE DERIVATIVE WITH ANTI-CONVULSIVE ACTIVITY, AND PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS CONTAINING THIS COMPOUND.
NL179202C (en) PROCESS FOR PREPARING ALKYNYL CYCLOPROPANIC CARBOXYLATES, AND AT LEAST CONTAINING SUCH COMPOUND INSECTICIDE PREPARATIONS.
NL7416022A (en) METHOD FOR PREPARING A MEDICINAL PRODUCT, SUCH MEDICINAL PRODUCT AND METHOD FOR PREPARING THE MEDICINAL COMPOUNDS REQUIRED FOR THIS REQUIREMENT.
NL186088C (en) PROCESS FOR PREPARING A MEDICINAL PRODUCT, WITH AN EFFECT ON THE CENTRAL NERVOUS SYSTEM CONTAINING AT LEAST ONE DERIVATIVE OF AN AMINO-THIENOBENZO-N-HETEROSOVEN COMPOUND, AND PROCESS FOR THE PREPARATION OF THIS PRODUCT
NL175812C (en) PROCESS FOR PREPARING AND / OR MANUFACTURING A MEDICINAL PRODUCT WITH ANTI-INFLAMMATORY EFFECT, AND METHOD FOR PREPARING A 2,6-SUBSTITUTED SUBSTITUTED DERIVATIVE DERIVATIVE THEREOF.
NL149375B (en) METHOD OF PREPARING A MEDICINAL PRODUCT ACTING ON THE CENTRAL OR PERIPHERAL NERVOUS SYSTEM CONTAINING AS THE ACTIVE INGREDIENT A 2-AMINOETHANOL DERIVATIVE.
NL180422C (en) METHOD FOR PREPARING MEDICINES WITH AN ANTIMICROBE ACTIVITY, AND METHOD FOR PREPARING A CEPHALOSPORINE COMPOUND WITH A THIADIAZOLYLTHIOMETHYL OR TETRAZOLYLTHIOMETHYL-SUBOMETHYL-3-SUBTHOMETHYL
NL145142B (en) METHOD OF PREPARING A MEDICINAL PRODUCT WITH ACTION ON THE NERVOUS SYSTEM, FORMED MEDICINAL PRODUCT, AND METHOD FOR PREPARING SUITABLE MEDICINAL COMPOUNDS.
NL167697C (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION ACTING ON THE CENTRAL NERVOUS SYSTEM BASED ON 5-PHENYLBENZODIAZEPINE DERIVATIVES, AND METHOD FOR PREPARING 5-PHENYLBODODIA ZEPARIC THESE BEFORE USE THEREFORE
NL181257B (en) METHOD FOR PREPARING A MEDICINAL PRODUCT WITH ANTICARIES AND ANTIPERIODONTITIS OPERATION, METHOD FOR PREPARING COMPOUNDS SUITABLE THEREFOR AND MEDICINAL PRODUCT
NL7506210A (en) METHOD OF PREPARING A 1H-TETRA-SOLE DERIVATIVE AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS.
NL186962C (en) PROCESS FOR PREPARING AN A204A DERIVATIVE, AND PROCESS FOR PREPARING A VETERINARY MEDICINAL PRODUCT WITH ANTICOCCIDE AND ANTIMICROBILE ACTION
NL7612894A (en) PROCEDURE FOR THE PREPARATION OF HETEROCYCLIC COMPOUNDS ACTING ON THE CENTRAL NERVOUS SYSTEM, PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH SUCH ACTION AND MEDICINAL PRODUCT.
NL184221C (en) PROCESS FOR PREPARING 3- (17BETA-HYDROXY-4-ANDROSTONE-3-ON-17ALFA-YL) PROPIOLACTONE AND A MEDICINAL PRODUCT CONTAINING THIS COMPOUND
NL7411859A (en) METHOD FOR PREPARING A MEDICINAL PRODUCT.
NL7604882A (en) PROCEDURE FOR THE PREPARATION OF BICYCLOOCTA DERIVATIVES ACTING ON THE CENTRAL NERVOUS SYSTEM, PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH SUCH ACTION AND OF ANY MEDICINAL PRODUCT.
NL7612610A (en) PROCEDURE FOR PREPARING IMIDAZOLE COMPOUNDS AND PROCEDURE FOR PREPARING A MEDICINAL PRODUCT WITH ANTI-URICOPATHETIC ACTION.
NL7410376A (en) PROCESS FOR PREPARING A FUNGICIDE.
NL143216B (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ACTION ON THE CENTRAL NERVOUS SYSTEM.
NL148238B (en) PROCESS FOR PREPARING A MEDICINAL PRODUCT ACTING ON THE CENTRAL NERVOUS SYSTEM.
NL171806C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT WITH ANALGETIC AND / OR ANTI-COUGHING ACTION, AND METHOD FOR PREPARING A BENZAZONINE COMPOUND
NL7508818A (en) PROCESS FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE COMPOUNDS, PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT ACTING ON THE CENTRAL NERVOUS OR HYPOTENSION ACTION AND A MEDICINAL PRODUCT.
NL183356C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION WITH STIMULATING EFFECT ON THE CENTRAL NERVOUS SYSTEM, AND METHOD FOR PREPARING THE USE OF 5-SUBSTITUTED-2-OINOPERATED-OIN-ATERO-PERIATED OIL-ATO-OXYPHYLENE OXYPHANE.
NL7416255A (en) PROCESS FOR PREPARING AN ORGANOTIN COMPOUND.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BK Erratum

Free format text: CORRECTION TO PAMPHLET

V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 951126